Newsroom

Sorted by: Latest
-

Walmart and Google Turn AI Discovery Into Effortless Shopping Experiences

BENTONVILLE, Ark.--(BUSINESS WIRE)--Today, Walmart Inc. and Google share plans to launch a new experience that pairs the intelligence of Google’s Gemini with Walmart and Sam’s Club’s unmatched assortment, value and convenience, to make shopping more intuitive, reliable and perfectly aligned with the rhythms of everyday life. The new experience — built by Walmart and accessible directly within Gemini using the Universal Commerce Protocol — addresses several key customer needs: Great items, at gr...
-

Sensormatic Solutions Enhances Storefront Design, Supports Retail Media Efforts and Delivers Shrink Insights With Flexible Loss-prevention & Engagement Experience System (FLEX)

NEUHAUSEN, Switzerland--(BUSINESS WIRE)--Sensormatic Solutions, the leading global retail solutions portfolio of Johnson Controls (NYSE: JCI), has added a new, highly customizable and retail-media-ready electronic article surveillance (EAS) system to its portfolio. The Sensormatic Solutions Flexible Loss-prevention & Engagement Experience (FLEX) platform is designed to enhance front-of-store real estate by combining visual merchandising, digital content management tools, and a full suite of...
-

Xerox and Lexmark Debut Unified Retail Tech at NRF 2026

NEW YORK--(BUSINESS WIRE)--Xerox and Lexmark today unveil a unified suite of retail solutions at NRF 2026: Retail’s Big Show, marking their first joint industry appearance. The newly combined company’s offering signals a new era in retail technology and introduces innovations designed to help brands “See It, Show It, Support It, Scale It.” The suite of offerings from the newly combined company showcases decades of expertise at the world's largest retail trade show, running through Jan. 13 at th...
-

Impinj and EM Microelectronic Announce Gen2X Licensing Agreement

SEATTLE--(BUSINESS WIRE)--Impinj, Inc. (NASDAQ: PI), a leading RAIN RFID provider and Internet of Things pioneer, today announced a licensing agreement with EM Microelectronic, a semiconductor manufacturer specialized in the design and production of ultra-low power, low voltage integrated circuits (IC), to integrate Impinj Gen2X into future EM endpoint ICs. “We are committed to enabling a broader ecosystem of product and technology providers to deliver powerful solutions to an array of market s...
-

BBNX Investors Have Opportunity to Join Beta Bionics, Inc. Fraud Investigation with the Schall Law Firm

LOS ANGELES--(BUSINESS WIRE)--BBNX Investors Have Opportunity to Join Beta Bionics, Inc. Fraud Investigation with the Schall Law Firm...
-

ARDT Investors Have Opportunity to Lead Ardent Health, Inc. Securities Fraud Lawsuit with the Schall Law Firm

LOS ANGELES--(BUSINESS WIRE)--ARDT Investors Have Opportunity to Lead Ardent Health, Inc. Securities Fraud Lawsuit with the Schall Law Firm...
-

Blockstream Capital Partners anuncia la adquisición estratégica del equipo de trading de derivados de Numeus Group, lo que habilita su alianza estratégica con Komainu

ST. HELIER, Jersey--(BUSINESS WIRE)--Blockstream Capital Partners (“BCP”) anunció hoy que ha suscrito un acuerdo estratégico para adquirir una división del negocio de trading e inversión en activos digitales de Numeus Group. La transacción contempla la incorporación de estrategias de trading selectas, enfocadas en Bitcoin y orientadas a la generación de rendimiento, así como de un equipo de diez profesionales especializados en trading de derivados, liderado por el Director de Inversiones, Deepa...
-

Kinaset Therapeutics Announces $103 Million Oversubscribed Series B Financing to Advance Novel, Inhaled Therapeutic Candidate for Respiratory Diseases

BOSTON--(BUSINESS WIRE)--Kinaset Therapeutics, a clinical-stage biopharmaceutical company developing a novel and differentiated inhaled therapeutic candidate to treat serious respiratory diseases, today announced the closing of a $103 million Series B financing. New investors RA Capital Management and Forge Life Science Partners led the financing, with participation from new investors EQT Life Sciences, Vivo Capital, Schroders Capital, Willett Advisors, Pictet Alternative Advisors, Sixty Degree...
-

Pfizer’s BRAFTOVI® Regimen with Additional Chemotherapy Backbone Increased Response Rates for Certain Patients with Metastatic Colorectal Cancer

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced positive results from Cohort 3, a separate randomized cohort of the pivotal BREAKWATER trial, evaluating BRAFTOVI® (encorafenib) in combination with cetuximab (marketed as ERBITUX®) and FOLFIRI (fluorouracil, leucovorin, and irinotecan) in patients with previously untreated metastatic colorectal cancer (mCRC) with a BRAF V600E mutation. At the time of this analysis, the BRAFTOVI combination regimen with FOLFIRI and cetuximab dem...
-

MindWalk fait avancer le programme universel de lutte contre la grippe grâce à des informations fonctionnelles pionnières

AUSTIN, Texas--(BUSINESS WIRE)--MindWalk Holdings Corp. (NASDAQ:HYFT) (« MindWalk » ou la « société »), une société d'IA bio-native spécialisée dans la recherche et les technologies thérapeutiques, annonce aujourd’hui une avancée dans son programme universel de lutte contre la grippe à la suite de l’identification d’une contrainte fonctionnelle révolutionnaire qui persiste à travers les virus de la grippe malgré une évolution continue. En utilisant sa technologie brevetée HYFT® Deep Data, MindW...